The Motley Fool

PHARMAXIS FPO (ASX: PXS) Share Price and News

 Chart and Price Data

20mins delayed

Bid/Ask /
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...


pharmaceutical shares

Is the Starpharma share price a buy?

The Starpharma Holdings Limited (ASX: SPL) share price has gained 50% since the end of December 2018. Is it a buy? More »

Warning: Every investor should read this before buying speculative biotech companies

You could lose your shirt investing in companies like Innate Immunotherapeutics Ltd (ASX:IIL). More »

This high-risk sector is one ALL new investors should avoid

Australia's fledging biotech sector, filled with the likes of Cynata Therapeutics Ltd (ASX:CYP) and Pharmaxis Ltd (ASX:PXS) is not for the faint-hearted. More »

laboratory testing medical health

Revealed: This under-the-radar biotech has blockbuster potential

Pharmaxis Ltd. (ASX:PXS) completes recruitment for Phase III cystic fibrosis trial. More »

Here’s why Prima Biomed Limited skyrocketed 59% today

Prima Biomed Limited (ASX:PRR) isn't the only biotech exploding recently, with Pharmaxis Ltd. (ASX:PXS) and Sirtex Medical Limited (ASX:SRX) on fire, too. Should you... More »

Here’s why Pharmaxis Ltd. skyrocketed 60% today

Pharmaxis Ltd. (ASX:PXS) shares gained more than 60% today, compared to a 1.1% decline for the ALL ORDINARIES (Index:^AXAO) (ASX:XAO). More »


Here’s why Pharmaxis Ltd. shares are soaring today

Pharmaxis Ltd (ASX:PXS) is just one of Australia's biotech stocks bouncing today, with its shares up nearly 65%! More »

fall down

6 stocks smashed on the ASX today

The All Ordinaries closes flat, despite a strong start to the day More »

Rocket liftoff

4 stocks soaring on the ASX today

S&P/ALL Ordinaries closes flat, but these four jumped more than 11% More »

The big reason why Pharmaxis Ltd shares slumped today

Biotech could be running out of options More »

Here’s why Bionomics Ltd shares soared today

Is this a new beginning for Bionomics? More »

Could these 4 bruised biotech stocks be about to recover?

Investing in the biotech sector can be hit or miss, but the hits can well and truly make up for the misses! More »